title: Epilepsy and brain tumors.
abstract: Seizures are common in patients with brain tumors, and epilepsy can significantly impact patient quality of life. Therefore, a thorough understanding of rates and predictors of seizures, and the likelihood of seizure freedom after resection, is critical in the treatment of brain tumors. Among all tumor types, seizures are most common with glioneuronal tumors (70-80%), particularly in patients with frontotemporal or insular lesions. Seizures are also common in individuals with glioma, with the highest rates of epilepsy (60-75%) observed in patients with low-grade gliomas located in superficial cortical or insular regions. Approximately 20-50% of patients with meningioma and 20-35% of those with brain metastases also suffer from seizures. After tumor resection, approximately 60-90% are rendered seizure-free, with most favorable seizure outcomes seen in individuals with glioneuronal tumors. Gross total resection, earlier surgical therapy, and a lack of generalized seizures are common predictors of a favorable seizure outcome. With regard to anticonvulsant medication selection, evidence-based guidelines for the treatment of focal epilepsy should be followed, and individual patient factors should also be considered, including patient age, sex, organ dysfunction, comorbidity, or cotherapy. As concomitant chemotherapy commonly forms an essential part of glioma treatment, enzyme-inducing anticonvulsants should be avoided when possible. Seizure freedom is the ultimate goal in the treatment of brain tumor patients with epilepsy, given the adverse effects of seizures on quality of life.
authors.affiliation: UCSF Comprehensive Epilepsy Center, University of California San Francisco, San Francisco, California, USA; Department of Neurological Surgery, University of California San Francisco, San Francisco, California, USA.
authors.forename: Dario J
authors.initials: DJ
authors.lastname: Englot
authors.affiliation: UCSF Comprehensive Epilepsy Center, University of California San Francisco, San Francisco, California, USA; Department of Neurological Surgery, University of California San Francisco, San Francisco, California, USA.
authors.forename: Edward F
authors.initials: EF
authors.lastname: Chang
authors.affiliation: Service Neurologie Mazarin, Groupe Hospitalier Pitié-Salpêtrière, Paris, France. Electronic address: charlesvecht@icloud.com.
authors.forename: Charles J
authors.initials: CJ
authors.lastname: Vecht
mesh_terms: D001932:Brain Neoplasms / Q000453:epidemiology / Q000209:etiology*; D004827:Epilepsy / Q000453:epidemiology / Q000209:etiology*; D005910:Glioma / Q000150:complications* / Q000175:diagnosis / Q000453:epidemiology; D006801:Humans
keywords: anticonvulsant; epilepsy; glioma; glioneuronal tumor; meningioma; metastasis; outcome; seizure